MMP Capital kicked off Q4/23 with $38.5 million in originations in October, marking 69% year-over-year growth for the month and following a third quarter in which it recorded 12% year-over-year growth, funding $85 million. Following its performance in the third quarter and October, MMP Capital is already flirting with its $400 million origination goal for 2023.

“It helps to be well capitalized in this market, which has been a key part of our success with our internal balance sheet, but we also have a strong demand for our paper from our key lending partners,” John-Paul Smolenski, CEO and president of MMP Capital, said. “Over the last 10 years, we have really put an emphasis on separating the MMP brand from competitors in the aesthetic healthcare market. This is largely due to our commitment to providing high-level service to all of our clients, vendors and key lending partners.”